Kristin Davis, Mary Kate Kelly, Donna Harris, Jennifer Steffes, Everly Macario, Samuel Wittman, Janani Ramachandran, Matthew Jones, Brigit Hatch, Julia Szymczak, Jonathan Yabes, Robert Grundmeier, Kristin Ray, Alexander Fiks Presented at the 2026 Pediatric Academic Societies Annual Meeting Background: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1s) are recommended as an adjunctive treatment to lifestyle interventions for weight loss in children 12 years and older
Frequently Asked Questions How long do I wait between semaglutide and tirzepatide
Similar to FDA-approved semaglutide and tirzepatide, FDA-approved liraglutide has been shown to help regulate blood sugar, curb appetite, and support weight loss by mimicking the action of a natural hormone involved in glucose metabolism and satiety
Read more What to Expect When Youre Taking Ozempic
Learn which medications to avoid while breastfeeding
Find articles by Welch, A